In particular, NQO1 can be a good therapeutic target for neurodegenerative diseases, including AD, because it is an inducible enzyme responsible for 2-electron transfer without the production of semi-quinone radicals [213,214]. The gene discussed is NQO1; the disease is neurodegenerative disease.